Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
Areas of Focus
Cardiometabolic
Severe Hypertriglyceridemia
Dyslipidemia
Cardiovascular Disease
Obesity
Pulmonary
Inflammatory Pulmonary Diseases
Idiopathic Pulmonary Fibrosis
Pipeline
Science & Innovation
Partnerships
Publications
Clinical Trials
Patients & Caregivers
What is RNAi?
Patient Centricity & Advocacy
Patient Stories
FCS Patient Insights
Expanded Access Programs
About
Leadership Team
Corporate Governance
Careers
Job Openings
Investors
Events & Presentations
Financial & Filings
Stock Information
Investor FAQs
Contact Us
Newsroom
Publications
Home
/
Science & Innovation
/
Publications
Filter by
Year Published
2025
2024
2023
2022
2021
2020
2019
2018
2017
2015
2013
2012
2011
2010
2007
2006
2005
2004
2003
2002
Selections
Clear Filters
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB
Read More
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
Read More
Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment
Read More
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
Read More
RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies
Read More
Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease
Read More
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
Read More
Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi
Read More
Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference
Read More
Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients
Read More
Prev
1
2
3
4
5
...
7
Next
